First Foal a Filly For GISW Win Win Win

Ocala Stud's Win Win Win (Hat Trick {Jpn}–Miss Smarty Pants, by Smarty Jones), winner of the GI Forego S. in 2020, was represented by his first foal when the Vindication mare Famous produced a filly at the Florida nursery Jan. 2.

“We are ecstatic about Win Win Win's first foal,” said Ocala Stud's David O'Farrell. “She is grand-looking, just like her sire.”

The bay is the sixth produce for her dam who has already been responsible for Grade III-placed juvenile filly Courteous (Midnight Lute). Famous is a daughter of GSW Statuette (Pancho Villa), making her a half-sister to Irish highweight Tomahawk (Seattle Slew). This is the extended Peter Blum family of GISW Well Chosen (Deputy Minister) and GSWs Academy Award (Secretariat) and Good Mood (Devil's Bag).

The post First Foal a Filly For GISW Win Win Win appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

FOX Sports and NYRA Reach Exclusive Belmont Stakes Deal

The New York Racing Association, Inc. (NYRA) and FOX Sports have reached an agreement with the latter acquiring exclusive media rights for the GI Belmont Stakes, beginning in 2023. The eight-year agreement runs through 2030 and includes the entire Belmont Stakes Racing Festival, which is the multi-day event of top races preceding the Belmont S., as well as a new title sponsorship deal which grants NYRA Bets the title sponsorship to the Belmont S.

“FOX Sports has quickly become the year-round home of the finest Thoroughbred racing in the country,” said Dave O'Rourke, NYRA President & CEO. “Their commitment to presenting innovative and informative coverage has had an enormous impact on reaching new fans and enhancing overall interest in the sport. That's why NYRA is so pleased to expand our partnership to now include the Belmont Stakes on FOX for many years to come.”

Michael Mulvihill, FOX Sports Executive Vice President, Head of Strategy and Analytics, said that acquiring the media rights to the Belmont was a perfect fit for a network that has embraced horse racing and seeks to expand its presence in the gaming market. Fox has an ownership stake in NYRA Bets.

“There are two primary reasons for this,” he said. “The first and simplest is that we are obviously a premium live sports brand. That's what we build our business on. Any time we have an opportunity to add something that is a championship event that's known to not just horseplayers but to every American sports fan, it just fits in with what we want our identify to be. We want to be a leader in live sports event programming. That's the most basic attraction to us.

“Alongside that, is the fact that we like to believe we are evolving from being purely a media content company into being more of a content and gaming company. Our Fox Bet brand is an important part of that. The relationship we have with NYRA and the partnership we have with NYRA Bets is a very important part of that. To be able to add the Belmont Stakes and see that as an engine to the continued growth of NYRA Bets is part of our continuing evolution into more of a gaming company.”

Mulvihill said that Fox's Belmont coverage will be more geared toward the horseplayer than what has been a typical broadcast of a Triple Crown event.

“We are going to be a little more willing to acknowledge that wagering is the lifeblood of the sport,” he said. “We want to put a product on the air that appeals to the people who are playing the races regularly.”

NYRA and FOX Sports began their collaboration with Saratoga Live in 2016 at Saratoga Race Course with 80 hours of live coverage on FOX Sports 2. That coincided with the national launch of NYRA Bets, NYRA's mobile wagering platform now available in more than 30 states. The total coverage of horse racing on FOX Sports has grown every year since the partnership began, eclipsing 700 hours in 2020. FOX Sports became the national television home for Belmont Park in 2019, began televising the GI Runhappy Travers to a national audience on the FOX broadcast network, also in 2019, and expanded the partnership with NYRA in March 2021 with a landmark media rights agreement. The latter agreement provides a FOX Sports subsidiary with an option to increase its current 25% equity interest in NYRA Bets.

“I don't agree at all that the sport isn't doing well,” Mulvihill said. “If you look at national handle figures for the year that just concluded nationwide betting is at a 12-year high. I don't know how many sports have key business metrics that are hitting 12-year highs right now.”

The Belmont S., the final jewel of the Triple Crown, was previously shown on NBC from 2001-05, ABC/ESPN from 2006-10, and on NBC from 2011, where it will be again shown in 2022 before moving to FOX Sports.

The post FOX Sports and NYRA Reach Exclusive Belmont Stakes Deal appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

California Vet Blea’s License Suspended on Interim Basis

The California Veterinary Medical Board has filed an interim suspension order against the license of Jeff Blea, the UC Davis Equine Medical Director who advises the California Horse Racing Board on matters relating to equine health and welfare. The order reads, “The allegations include prescribing, dispensing, and/or administering thyroxine and other drugs to racehorses without establishing a veterinarian-client-patient relationship (VCPR), without performing an examination, without forming a diagnosis, and without medical necessity.”

According to John Cherwa at the Los Angeles Times, an emergency hearing was held Dec. 24, and Administrative Law Judge Nana Chin signed the temporary suspension order.

The petitioner for the order was Jessica Sieferman, the Executive Officer of the California Veterinary Medical Board, and was filed by Rob Bonta, the Attorney General of California. They write in her petition that “the Board is investigating licensed veterinarians who have prescribed, dispensed, or administered drugs to racehorses, and the medical necessity of such drugs.”

The filing suggests that as a practicing veterinarian, Blea has a vested interest in the findings of the Medina Spirit necropsy, and that suspending his license will “prevent the appearance of impropriety,” while failing to clearly connect the dots as to why Blea specifically would have a vested interest simply by virtue of being a veterinarian or in his administrative roles.

It reads, “Because Respondent Blea is alleged to have administered dangerous and medically unnecessary drugs to numerous racehorses, it stands to reason that he approves of such practice by other veterinarians. Any necropsy and investigation results identifying any racehorse's cause of death as drug-related would be detrimental to Respondent Blea, his career, and his livelihood. With the Board's allegations pending, there exists a clear conflict of interest with Respondent Blea's continued involvement in the drug testing program and investigations. The requested interim suspension order will prevent the appearance of impropriety and any possible undue influence by Respondent Blea. The Medina Spirit investigation is currently underway. An impartial, complete and transparent investigation without undue influence and the appearance of impropriety is necessary to determine the root cause of Medina Spirit's death so that remedial action can be taken to prevent additional equine deaths.”

The filing goes on to say that Blea treated six horses with “dangerous drugs” without showing that he completed a “proper physical examination. A proper physical examination would consist of a documented general organ-system examination and may consist of more detailed and focused examinations of particular areas of interest.” It says that Blea “administered at least one of the following dangerous drugs…Thyro-L, Lasix, acepromazine, Adequan, phenylbutazone, methocarbamol, glycopyrrolate, trichlomethiazide/dexamethasone, Dormosedan, and Torbugesic.”

“Respondent Blea is alleged to have committed medication violations on racehorses and is part of the team that oversees the UC Davis drug testing program and investigates medication violations. The appearance of the impropriety alone erodes public trust. The mission of the Board is to protect consumers and animals. Adequate protection of racehorses requires learning the true causes of their sudden deaths so proper remedial action can be taken. That can only happen with impartial, complete and transparent investigations. Petitioner requests the Court to grant the interim suspension order suspending Respondent Blea's license,” the report concludes.

Blea is a respected veteran of the veterinary medical field, both in California and nationally. Aside from decades of equine practice, during which time he has been associated with some of the most well-regarded horsemen in the business, like Richard Mandella, Blea is also a former chair of the American Association of Equine Practitioners' Racing Committee. He also sits on the Horseracing Integrity and Safety Act's Anti-Doping and Medication Control Standing Committee.

The post California Vet Blea’s License Suspended on Interim Basis appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

CHRB Investigative Reports Add Details to NYRA’s Amended Charges Against Baffert

In a press release Monday, the New York Racing Association (NYRA) announced that it had amended its ongoing Statement of Charges issued against trainer Bob Baffert to include a pair of positive tests for phenylbutazone (bute) in 2019 in California and a subsequent inspection of the trainer's barn which allegedly uncovered an unlocked medication cabinet, improperly labeled medications and the presence of unsecured phenylbutazone paste.

NYRA has charged Baffert with engaging in conduct detrimental to the best interests of racing and has sought to temporarily ban the trainer from its tracks. A hearing on the matter is scheduled to begin Jan. 24.

Dr. Rick Arthur, who was the California Horse Racing Board (CHRB) equine medical director at the time of the 2019 violations, told TDN Monday that barn inspections are “routine” after a post-race medication positive, and that there is no regulatory requirement for drug cabinets to be locked, even though the board strongly encourages medications to be securely stored.

Arthur also explained that the proper labeling of medications is primarily the veterinarian's responsibility, and that a crucial question is: What were the mislabeled drugs?

“If it's Gastrogard tubes out of the box,” said Arthur Monday, pointing to a commonly used ulcer medication, “it's a technical violation, and not a serious one at all. If it was serious, an official warning or complaint would have been filed against either the trainer or the dispensing veterinarian.”

The investigation reports for the barn inspections–obtained through a California Public Records Act (CPRA) request–shed some light on the nature of NYRA's amended complaint but fail to answer the issue of what the mislabeled drugs actually were.

No subsequent warnings or complaints were filed against either Baffert or the attending veterinarian, Dr. Vince Baker, however.

The Del Mar barn inspection identified by the NYRA press release pertains to the one conducted Aug. 16, after the Baffert-trained Eclair (Bernardini) tested positive for bute after finishing 4th at Del Mar Aug. 3. Baffert was fined $1,500. Eclair tested positive with 2.88 micrograms per milliliter (ug/mL) of bute in her system.

According to the report, the investigator found “25 different kinds of medications that are not properly labeled and expired. There is no lock on the medication cabinet however the tack room door has lock capabilities. Dr. Vince Baker advised he would be taking care of the situation.”

According to the report, Baker told the investigator he did not know how Eclair tested positive for bute. “Baffert stated he thinks someone is intentionally giving bute to his horses and mentioned that he would be offering a reward to help solve the case,” the report added.

According to the report, Baker told the investigator he had treated Eclair no later than 10:30 am two days before the race.

Baker also told the investigator that he treated other Baffert runners with bute the following day, but that he “does not believe he inadvertently treated 'Eclair' by mistake,” according to the report.

The CHRB conducted a separate inspection of Baffert's Del Mar barn Aug. 10, after Cruel Intention (Smiling Tiger) tested positive for bute after finishing 3rd at Del Mar July 27 in the Real Good Deal S.

Baffert was fined $500. Cruel Intention tested positive with 0.51 ug/mL of bute in his system.

In light of the Santa Anita welfare crisis the spring of 2019, the CHRB reduced just months earlier the permissible level of race-day bute from 2 ug/mL to a level of non-detect.

Six days prior to the second barn inspection, the CHRB investigator found “expired medications and those that were up to date were properly labeled. There is no lock on the medication cabinet however the door has lock capabilities,” according to the inspection report.

According to the report, Baker told the investigator he treated three of Baffert's horses at the same time with bute, “and does not know why only one horse [Cruel Intention] tested positive for it.”

The two inspection reports can be read here and here.

The post CHRB Investigative Reports Add Details to NYRA’s Amended Charges Against Baffert appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights